Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Sees Significant Decline in Short Interest

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the recipient of a large decline in short interest in the month of May. As of May 29th, there was short interest totaling 118,738 shares, a decline of 33.8% from the May 14th total of 179,478 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Shin Nippon Biomedical Laboratories Price Performance

Shares of Shin Nippon Biomedical Laboratories stock opened at $7.00 on Tuesday. The company’s fifty day moving average price is $8.94 and its two-hundred day moving average price is $9.62. Shin Nippon Biomedical Laboratories has a 52-week low of $7.00 and a 52-week high of $9.16.

About Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.